Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
affiliate, attain, baseline, Biden, blistering, bulk, calendar, cardiac, constitute, convincing, designee, drop, entitled, entrance, evidence, freely, hedging, imply, JAMA, local, mandatory, multicenter, necessity, nonbinding, nonclinical, oversite, pharmacoeconomic, Portugal, preempt, relaxation, robust, shelf, Sopaharma, Spain, supplement, tableting, thereof, unanimously, unexercised, uniform, unprofitable
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view